Literature DB >> 33178823

Corrigendum to "miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1".

Xu Jia-Yuan1, Song Wei1, Lu Fang-Fang1, Dai Zhi-Jian1, Cao Long-He1, Lin Sen1.   

Abstract

[This corrects the article DOI: 10.1155/2020/9704245.].
Copyright © 2020 Xu Jia-yuan et al.

Entities:  

Year:  2020        PMID: 33178823      PMCID: PMC7648670          DOI: 10.1155/2020/3595402

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


In the article titled “miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1” [1], the Y-axes labelling of Figures 1(a) and 1(b) were inverted by mistake. The corrected figure is shown below and is listed as Figure 1.
Figure 1

Expression levels of miR-375 and PDK1 in NPC tissues and cell lines were assessed. (a, b) qRT-PCR was performed to measure expression levels of miRNAs and PDK1 in 23 normal samples and in 38 NPC samples. miR-375 is downregulated in NPC tissue, compared with normal tissue, while PDK1 is upregulated in NPC tissue, compared with normal tissue (Student's t-test, ∗∗P < 0.01). (c, d) qRT-PCR was performed to evaluate miR-375 expression in the N69 epithelial normal nasopharynx cell line and NPC cell lines (CNE-1,CNE-2, C666-1, and HONE1). Conversely, levels of PDK1 were markedly increased in NPC cell lines, compared to NP69 (CNE-1, CNE-2, C666-1, and HONE1) (Student's t-test, ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001). Cell lines CNE-2 and CNE-1 showed the greatest difference in miR-375 expression levels when compared to NP69 cells and were used for subsequent analyses. Each assay was conducted in duplicate, three times. Values are presented ±s.e.m.

  1 in total

1.  miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1.

Authors:  Xu Jia-Yuan; Song Wei; Lu Fang-Fang; Dai Zhi-Jian; Cao Long-He; Lin Sen
Journal:  Biomed Res Int       Date:  2020-03-21       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.